Anti-Hu CD263 Purified Azide Free

Anti-Hu CD263 Purified Azide Free
Regulatory status
RUO
Antigen
CD263
Clone
TRAIL-R3-02
Format
Purified Azide Free
Reactivity
Human
Application
FC (QC tested)
Variant
0.1 mg
10-518-C100
In stock

0.025 mg
10-518-C025
Out of stock
Variant
0.1 mg
11-261-C100
In stock

0.1 mg
11-261-C100
In stock
Product details
Images
References
Isotype
Mouse IgG1
Specificity
The antibody TRAIL-R3-02 reacts with TRAIL-R3, a 35 kDa GPI-anchored extracellular membrane protein expressed mainly on neutrophils.
Application
FC (QC tested)
Reactivity
Human
Immunogen
TRAIL-R3 (aa 1-280) - hIgGhc fusion protein
Other names
TNFRSF10C, Decoy receptor 1, DcR1, TRAIL receptor 3, TRAIL-R3, TRAILR3, TRID, LIT
Concentration
1 mg/ml
Preparation
Purified by protein-A affinity chromatography
Formulation
Azide free phosphate buffered saline (PBS), approx. pH 7.4
Storage and handling
Store at 2-8°C. Do not freeze. Do not use after expiration date stamped on vial label.
Exbio licence note
Unless indicated otherwise, all products are For Research Use Only and not for diagnostic use. In vivo diagnostic or therapeutic applications are strictly forbidden. Products shall not be used for resale or transfer to third parties either as a stand-alone product or as a manufacture component of another product without written consent of EXBIO Praha, a.s. EXBIO Praha, a.s. will not be held responsible for patent infringement or any other violations of intellectual property rights that may occur with the use of the products. Orders for all products are accepted subject to the Term and Conditions available at www.exbio.cz. EXBIO, EXBIO Logo, and all other trademarks are property of EXBIO Praha, a.s. © 2019 EXBIO Praha, a.s. All rights reserved.
10-518_FC_Profil Značení
Flow cytometry surface staining pattern of CD263 transfected HEK-293 cell suspension using anti-human CD263 (TRAIL-R3-02) purified antibody (azide free, concentration in sample 16 μg/ml) GAM APC.
10-518_FC_Histogram
Separation of CD263 transfected HEK-293 cells (red-filled) from nontransfected HEK-293 cells (black-dashed) in flow cytometry analysis (surface staining) stained using anti-human CD263 (TRAIL-R3-02) purified antibody (azide free, concentration in sample 16 μg/ml) GAM APC.

General references:

Deligezer U, Dalay N: Expression of the TRAIL Receptors in Blood Mononuclear Cells in Leukemia. Pathol Oncol Res. 2007;13(4):290-4.
PubMed
Falschlehner C, Emmerich CH, Gerlach B, Walczak H: TRAIL signalling: decisions between life and death. Int J Biochem Cell Biol. 2007;39(7-8):1462-75.
PubMed
Mérino D, Lalaoui N, Morizot A, Schneider P, Solary E, Micheau O: Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2. Mol Cell Biol. 2006 Oct;26(19):7046-55.
PubMed
Sanlioglu AD, Dirice E, Aydin C, Erin N, Koksoy S, Sanlioglu S. Surface TRAIL decoy receptor-4 expression is correlated with TRAIL resistance in MCF7 breast cancer cells. BMC Cancer. 2005 May 25;5(1):54.
PubMed
Clancy L, Mruk K, Archer K, Woelfel M, Mongkolsapaya J, Screaton G, Lenardo MJ, Chan FK: Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis. Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18099-104.
PubMed
Variant
0.1 mg
10-518-C100
In stock

0.025 mg
10-518-C025
Out of stock
Variant
0.1 mg
11-261-C100
In stock

0.1 mg
11-261-C100
In stock